The Quebec Division of the Multiple Sclerosis Society of Canada (MSSC) announced that this year’s 27th Medavie Blue Cross MS Bike, a fundraising bike ride on roads alongside St. Lawrence River, will take place Aug. 27 and 28 in the Mauricie region.
A total of 900 cyclists are set to participate in the ride, which traverses the region’s villages, to raise money for multiple sclerosis (MS) research and to add to the nearly $17 million MS Bike has raised since its inception. The Medavie Blue Cross MS Bike is organized by MSSC in collaboration with Vélo Québec Événements.
“Medavie Blue Cross is thrilled to be title sponsor of the MS Bike Tour in Quebec again this year,” Eric Laberge, president of Medavie Blue Cross, said in a press release. “Multiple sclerosis is a leading health concern for Canadians. We are committed to supporting research and programs to help those impacted by MS through our support of the MS Society.
“The MS Bike Tour is a fun and healthy event that has a tremendous impact in our province,” he added. “Together with our employees, we care about our community’s health and believe that we can build a future without MS.”
Canada has the highest rate of MS in the world.
Spokeswoman for this year’s event is Valérie Chevalier, a columnist with Salut, Bonjour!, who will cycle with her friend and team leader Christiane Thouin, an MS patient.
MS Bike is the largest cycling fundraising event in North America, with tours involving more than 10,000 cyclists taking place from June to September across the country. Anyone interested in finding out more out these rides can visit msbike.ca.
MS, a chronic and disabling disease of the central nervous system (CNS), is often diagnosed in people between the ages of 15 and 40. The MSSC supports research into the cause, improved treatments, and a potential cure for MS, and provides services for patients and their families.
To keep updated on events like this, as well as developments in ongoing research into multiple sclerosis, subscribe to Multiple Sclerosis News Today and receive our weekly newsletter directly in your email.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?